Cargando…
Effectiveness of risk minimisation measures for valproate: A drug utilisation study in Europe
PURPOSE: The purpose of this study was to evaluate the effectiveness of the risk minimisation measures (RMMs) implemented in Europe in 2014 for valproate‐containing products to mitigate their risk during pregnancy and to characterise valproate prescribing patterns in women of childbearing potential...
Autores principales: | Toussi, Massoud, Shlaen, Margarita, Coste, Florence, de Voogd, Hanka, Dimos, Vasilis, Kaplan, Sigal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894134/ https://www.ncbi.nlm.nih.gov/pubmed/33108674 http://dx.doi.org/10.1002/pds.5166 |
Ejemplares similares
-
Effectiveness of risk minimisation measures for valproate: A cross‐sectional survey among physicians in Europe
por: Toussi, Massoud, et al.
Publicado: (2020) -
Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study
por: Abtahi, Shahab, et al.
Publicado: (2023) -
Evaluating the Effectiveness of Apixaban Additional Risk Minimisation Measures Using Surveys in Europe
por: Mayall, Steve, et al.
Publicado: (2021) -
Introduction or Discontinuation of Additional Risk Minimisation Measures During the Life Cycle of Medicines in Europe
por: Francisca, Reynold D. C., et al.
Publicado: (2020) -
A review of the sampling methodology used in studies evaluating the effectiveness of risk minimisation measures in Europe
por: Jouaville, Laurence Sophie, et al.
Publicado: (2021)